Mittag O, Döbler A, Pollmann H, Farin-Glattacker E, Raspe H
Institut für Qualitätsmanagement und Sozialmedizin, Universitätsklinikum Freiburg.
Klinik Niederrhein der DRV Rheinland, Bad Neuenahr-Ahrweiler.
Rehabilitation (Stuttg). 2014 Oct;53(5):313-20. doi: 10.1055/s-0034-1370984. Epub 2014 Oct 15.
Type 2 diabetes (DM II) is the world's most widespread metabolic disease. Numerous investigations have demonstrated that intensive, multimodal interventions can reduce the occurrence of DM-associated comobidities and mortality. Medical rehabilitation could offer such an alternative, albeit one with an obvious time limit. There is currently no active program in Germany designed to screen for pa-tients' need for rehab. Here, we investigated -whether screening for rehab need in DMII pa-tients accompanied by written advice to file an application for rehab treatment would generate a relevant number of rehab measures, whether -inpatient rehab results in improved mid-term prognoses, and which patients demonstrate a particular benefit from such a program.
We screened 5 500 employed individuals aged 18-54 years for their need for rehab via an extensive questionnaire based on the "Lübeck Algorithm". The patients were registered in the DMP (disease management program) Diabetes mellitus Type 2 in the AOK Rheinland/-Hamburg health insurance division, and payed into DRV (German statutory pension insurance -scheme) Rheinland retirement insurance. Pa-tients needing rehab who presented no exclusion criteria (i. e., for a rehab intervention far from their place of residence) were randomized to a control or intervention group at a ratio of 3:1. Patients in the intervention group received a letter from the AOK advising them to fill out an application for rehab. A very short, simple application form was included in the mailing. 12 months after randomization we conducted a query to determine the effects of rehab. Our primary endpoint was a cardiovascular risk score specifically devised for diabetics. Multi-level models were applied to measure changes in cardiovascular risk.
850 patients (rate of return=16%) returned completed screening forms to us. After having excluded those with faulty diagnoses and/or those who had refused to participate, 829 patients remained. 94% of them presented a need for rehab according to specific criteria (39% with a simple and 55% with complex problem profiles). 266 patients stated in the questionnaire that a rehab program was impossible for them for personal reasons. Of those patients who remained, we randomized 299 to the intervention cohort and 102 to the control group. Almost 70% of the intervention group completed an application for rehab, and our follow-up revealed that most of them participated in a rehab intervention. Return rate after one year was 82%. Analysis on the intention-to-treat (ITT) principle revealed no significant effect on cardiovascular risk (p=0.68); however, per-protocol analysis demonstrated a significant effect in the intervention cohort (p=0.025). Males, and patients with an uncomplicated problem profile profited from the intervention.
We discovered that a proactive procedure leads to the identification of a highly relevant group of insured individuals, and that it is suited to generating a large number of medically -justified rehab applications. ITT analysis on the effi-cacy of inpatient rehabilitation for type 2 diabetes mellitus in terms of the cardiovascular 5-year risk, however, failed to display a significant statistical effect in this study population (insurees of generally lower socioeconomic status having no intention to apply for rehab treatment). Rehab treatment for type 2 diabetes does not seem to be universally effective. This of course does not apply to rehab in general, as patients usually participate in rehab of their own volition. More research is needed on this issue.
2型糖尿病(DM II)是全球最普遍的代谢性疾病。大量研究表明,强化的多模式干预可降低糖尿病相关合并症的发生率及死亡率。医学康复或许能提供这样一种选择,尽管其存在明显的时间限制。目前德国尚无旨在筛查患者康复需求的现行项目。在此,我们调查了对DMII患者进行康复需求筛查并附上申请康复治疗的书面建议,是否会产生相当数量的康复措施,住院康复是否能改善中期预后,以及哪些患者能从此项目中特别受益。
我们通过基于“吕贝克算法”的广泛问卷,对5500名年龄在18 - 54岁的在职人员进行康复需求筛查。这些患者在AOK莱茵兰/汉堡医疗保险部门的2型糖尿病疾病管理项目(DMP)中登记,并缴纳DRV(德国法定养老保险计划)莱茵兰养老保险。无排除标准(即康复干预地点离居住地过远)的康复需求患者按3:1的比例随机分为对照组和干预组。干预组患者收到AOK的一封信,建议他们填写康复申请。邮件中包含一份非常简短、简单的申请表。随机分组12个月后,我们进行询问以确定康复效果。我们的主要终点是专门为糖尿病患者设计的心血管风险评分。应用多水平模型来测量心血管风险的变化。
850名患者(回复率 = 16%)向我们返回了填写完整的筛查表。排除诊断错误和/或拒绝参与的患者后,剩余829名患者。其中94%根据特定标准存在康复需求(39%为简单问题情况,55%为复杂问题情况)。266名患者在问卷中表示因个人原因无法参加康复项目。在剩余患者中,我们将299名随机分配至干预队列,102名至对照组。干预组近70%的患者完成了康复申请,我们随访发现他们中的大多数参与了康复干预。一年后的回复率为82%。意向性分析(ITT)显示对心血管风险无显著影响(p = 0.68);然而,符合方案分析表明干预队列有显著影响(p = 0.025)。男性以及问题情况不复杂的患者从干预中获益。
我们发现积极主动的程序能识别出大量具有高度相关性的参保个体群体,且适合产生大量有医学依据的康复申请。然而,就心血管5年风险而言,对2型糖尿病住院康复疗效的ITT分析在该研究人群(社会经济地位普遍较低且无意申请康复治疗的参保者)中未显示出显著的统计学效果。2型糖尿病的康复治疗似乎并非普遍有效。当然,这并不适用于一般的康复治疗,因为患者通常是自愿参与康复的。关于这个问题还需要更多研究。